GL1X · GenesisL1 explorer

Ligand · TAQ

TAQ · 2,4,6-triaminoquinazoline

TAQ, 2,4,6-triaminoquinazoline (C8 H9 N5, 175.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found with it.

Component
TAQ
Formula
C8 H9 N5
Class
ligand
Structures
2
PDB entries
1

Binding sites

TAQ in 2 structures; the first of them:

  • 1W0C · Inhibition of Leishmania major pteridine reductase (PTR1) by 2,4,6-triaminoquinazoline… · TAQ A301 · binds ARG17, SER111, PHE113, ASP181, TYR194, LEU229
  • 1W0C · Inhibition of leishmania major pteridine reductase (PTR1) by 2,4,6-triaminoquinazoline… · TAQ A301 · binds ARG17, SER111, PHE113, ASP181, TYR194, LEU229

Residues it binds most

SER 18, ASP 18, ARG 16, PHE 16, TYR 16, LEU 14, VAL 4, GLY 2 (residue and the binding sites it lines).

Found with

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.